Evidence-Based Management of Angioedema in Urgent Care (Pharmacology CME) | Points & Pearls
Click to check your cart0

Evidence-Based Management of Angioedema in Urgent Care (Pharmacology CME)

Below is a free preview. Log in or subscribe for full access. Or, get a free sample article Evidence-Based Management of Angioedema in Urgent Care:
Please provide a valid email address.

Points & Pearls Excerpt

  • Angioedema is broadly classified into 3 categories: (1) histamine-mediated, (2) bradykinin-mediated, and (3) idiopathic.4
  • Angioedema should be recognized as a symptom of a potentially life-threatening emergency. Histamine-mediated angioedema can progress rapidly to airway obstruction, anaphylaxis, or both. Bradykinin-mediated angioedema develops more slowly but can also result in laryngeal edema and airway obstruction.
  • The patient’s symptoms will help distinguish histamine- and bradykinin-mediated angioedema. See Figure 4.
To Read The Companion Article:
To Read The Companion Article:
To Read The Companion Article:
Publication Information
Author

Lorilea Johnson, FNP-BC, DNP

Peer Reviewed By

Tracey Quail Davidoff, MD, FCUCM; Robert K. Beam, MD, PhD, FAAFP; Eric Macy, MD, MS, FAAAAI

Publication Date

May 1, 2024

CME Expiration Date

May 1, 2027    CME Information

CME Credits

4 AMA PRA Category 1 Credits™. 4 AOA Category 2-B Credits.
4 AAFP Prescribed Credits
Specialty CME Credits: Included as part of the 4 credits, this CME activity is eligible for 1 Pharmacology CME credit.

Get Permission

Content you might be interested in
Get A Sample Issue Of Emergency Medicine Practice
Enter your email to get your copy today! Plus receive updates on EB Medicine every month.
Please provide a valid email address.